... the end in inflammation
Products
Resolvyx Pharmaceuticals is developing a pipeline of innovative resolvin therapeutics to treat multiple disease indications
Resolvins will through their endogenous origin provide a unique/risk benefit offering for the treatment of chronic inflammatory conditions.